$5.300
+0.187 (+3.52%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NXTC Prediction & Forecast by Similar Chart Analysis
Alphio's NXTC stock price prediction model matches the current NextCure Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.34 (+0.71%). The 1-week path is $5.26 (-0.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy NextCure Inc Stock?
NextCure Inc is not a good buy right now due to its current price of $5.30, which is significantly below its 52-week high of $15.74, indicating a potential for recovery but also substantial risk. The RSI is at 39.99, suggesting the stock is nearing oversold conditions, but the recent performance shows a 60.09% year-to-date decline, indicating ongoing weakness. The main risk is the substantial net losses reported, with a net income of -11603000 in Q4 2024 and -26808000 in Q2 2025, which raises concerns about the company's financial health and sustainability.
NXTC stock price ended at $5.30 on Friday, after rising +3.52%
NextCure Inc (NXTC) last closed at $5.3000002, gaining +3.52%. These facts feed the 1-day and 1-week NXTC price prediction above.
Forecast Drivers
NextCure Inc (NXTC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NXTC, ranked by similarity.
Seasonality analysis for NXTC
Historically the probability of a positive November return for NXTC is 65.91%. November offers the highest probability of a positive month at 65.91%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NXTC
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $4.59 | $4.76 | $5.59 | -10.23% |
| Dec 2026 | $5.77 | $5.99 | $6.77 | +12.96% |
In 2026, NextCure Inc (NXTC) is projected to range from $4.59 to $6.77.
NextCure Inc 2026 monthly forecast
In Nov 2026, NextCure Inc is projected to average $4.76, with a low of $4.59 and high of $5.59.
In Dec 2026, NextCure Inc is projected to average $5.99, with a low of $5.77 and high of $6.77.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.